Gabapentin for sleep
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin for Sleep: Efficacy, Safety, and Clinical Insights
Introduction to Gabapentin and Sleep Disorders
Gabapentin, originally developed as an anticonvulsant, has been increasingly studied for its potential benefits in treating sleep disturbances. This article synthesizes findings from multiple studies to provide a comprehensive overview of gabapentin's efficacy and safety in improving sleep quality across various conditions.
Efficacy of Gabapentin in Treating Sleep Disturbances
General Sleep Improvement
Several studies have demonstrated gabapentin's effectiveness in improving sleep quality. A systematic review and meta-analysis involving 4,684 participants found that gabapentin significantly improved various sleep outcomes compared to placebo, although it was associated with higher rates of treatment discontinuation due to adverse effects . Another meta-analysis focusing on patients with sensory nervous system diseases also reported significant improvements in sleep quality and reductions in sleep interference and awakenings .
Specific Conditions
Restless Legs Syndrome (RLS)
Gabapentin enacarbil, a prodrug of gabapentin, has shown significant benefits in patients with moderate-to-severe primary restless legs syndrome (RLS). Pooled analyses from three trials indicated that gabapentin enacarbil significantly improved sleep disturbance, mood, and pain scores compared to placebo .
Menopausal Women with Hot Flashes
In menopausal women experiencing hot flashes, gabapentin was found to improve sleep quality significantly. A study using the Pittsburgh Sleep Quality Index (PSQI) reported improvements in both global sleep quality and sleep efficiency scores at 4 and 12 weeks of treatment .
Alcohol Dependence
Gabapentin has also been studied in the context of alcohol dependence. A pilot trial found that gabapentin delayed the onset of heavy drinking and improved insomnia symptoms, although the improvements in sleep were not significantly different from placebo . Another study showed that gabapentin improved sleep efficiency and reduced awakenings in subjects who consumed alcohol before bedtime .
Safety and Tolerability
General Safety Profile
While gabapentin is generally well-tolerated, some studies have reported higher rates of adverse events compared to placebo. Common side effects include somnolence and dizziness . A meta-analysis found no significant differences in the incidence of adverse reactions between gabapentin and placebo groups, suggesting a relatively safe profile for short-term use .
Concerns with Sleep Apnea
A safety signal from the WHO pharmacovigilance database indicated a potential association between gabapentin and sleep apnea syndrome (SAS). The analysis found significant reported odds ratios for gabapentin and pregabalin, suggesting that these medications might exacerbate sleep-disordered breathing .
Conclusion
Gabapentin appears to be effective in improving sleep quality across various conditions, including sensory nervous system diseases, RLS, menopausal symptoms, and alcohol dependence. However, its use is associated with some adverse effects, and there is a potential risk of exacerbating sleep apnea. Further research is needed to confirm these findings and to explore the long-term safety of gabapentin for sleep disorders.
Sources and full results
Most relevant research papers on this topic
Efficacy and Safety of Gabapentin in Improving Sleep Quality of Patients with Sensory Nervous System Diseases: A Meta-Analysis.
Gabapentin is safe and effective in improving sleep quality in patients with sensory nervous-system diseases, reducing sleep interference and night awakenings without significant adverse reactions.
Gabapentin Increases Slow‐wave Sleep in Normal Adults
Gabapentin increases slow-wave sleep in normal adults, while reducing rapid-eye-movement sleep and sleep latency.
A Randomized, Double-Blind, Single-Dose, Placebo-Controlled, Multicenter, Polysomnographic Study of Gabapentin in Transient Insomnia Induced by Sleep Phase Advance
Gabapentin significantly increases sleep duration and depth in individuals with occasional disturbed sleep, compared to placebo.
A randomized, double-blind, placebo-controlled, multicenter, 28-day, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance.
Gabapentin 250 mg effectively increases sleep duration and reduces wake-up time in patients with transient insomnia, without causing next-day impairment.
DOI
Gabapentin improves sleep in the presence of alcohol.
A single dose of gabapentin at bedtime can improve sleep quality and reduce awakenings in individuals with frequent awakenings and decreased sleep efficiency.
DOI